Erste Asset Management’s Soleno Therapeutics SLNO Stock Holding History

Erste Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-25,600	Closed	-$779K	–	665
2026 Q1	$779K	Hold	25,600	–	–	0.01%	465
2025 Q4	$1.22M	Hold	25,600	–	–	0.01%	416
2025 Q3	$1.74M	Buy	25,600 +15,600	+156%	+$1.16M	0.02%	356
2025 Q2	$833K	Buy	+10,000	New	+$748K	0.01%	538

Erste Asset Management's SLNO Position: Q2 2026 in Review

Erste Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 25,600 shares — an estimated $779K sold.

Erste Asset Management first reported a position in SLNO in Q2 2025 and held it in 4 quarters. The position peaked at $1.74M in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Erste Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Erste Asset Management sold 25,600 Soleno Therapeutics shares in Q2 2026, an estimated $779K.
Erste Asset Management first reported a position in Soleno Therapeutics in Q2 2025 and held it in 4 quarters.
Erste Asset Management's Soleno Therapeutics position peaked at $1.74M in Q3 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.